Navigation Links
DuoCort AB: DuoCort announces Phase I Data Presentation at the,European Congress of Endocrinology

ient compliance. In addition, by combining rapid release and extended release characteristics, DuoCort's new tablet also delivers a more physiological dose of hydrocortisone, better mimicking the body's natural cortisol serum profile.

About adrenal insufficiency

Recent research on adrenal insufficiency patients taking currently available glucocorticoid replacement therapy demonstrates reduced bone density and unfavourable cardiovascular risk profiles. Recent data also suggest an almost 3-fold increased mortality. Chronic adrenal insufficiency is a rare disease that affects at least 125,000 patients in the European Union.

About DuoCort AB

DuoCort is a drug development company focussed on improving glucocorticoid therapy in several areas of medical need. DuoCort was founded in 2003 by PULS, an early-stage life sciences investment and business development group (www.pulsinvest.se). www.duocort.com

This information was brought to you by Cision http://newsroom.cision.com

Contact

DuoCort
Greg Batcheller, CEO, +46 73 391 9608


'"/>




Page: 1 2

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:9/3/2015)... Sep. 03, 2015 Research ... the "Investigation Report on China,s Entecavir Market, 2010-2019" ... of people infected with hepatitis B virus (HBV) exceeds ... which 20-30 million suffering from chronic Hepatitis B. About ... damage and liver cancer caused by chronic Hepatitis B, ...
(Date:9/3/2015)... 2015 Research and Markets ... "Investigation Report on China,s Raloxifene Market, 2010-2019" ... statistics, over 200 million people suffer from osteoporosis in ... China , 50% have low bone ... women aged 60 and above. Raloxifene (raloxifene hydrochloride), ...
(Date:9/3/2015)... China,s startup business ... a wearable medical device that can continuously monitor the ... safety guidance for pregnant women. The device will debut ... which measures 4 centimeters in diameter, is as thin ... than an Apple earphone cord. The small and compact ...
Breaking Medicine Technology:China Entecavir Market Report 2010-2019 2Investigation Report on China's Raloxifene Market, 2015-2019 2Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2
... MINNEAPOLIS, Oct. 21 In conjunction with National ... Technologies Inc. and Your Safety Company have announced ... Cardiac Arrest Foundation for every HeartSine® samaritan® PAD ... Cardiac Arrest Foundation before December 31, 2009. , ...
... Symmetry Medical Inc. (NYSE: SMA ), a leading independent ... other medical markets, announced today that it will release third ... 2009 before the market opens on Thursday, November 5, 2009. ... a.m. ET on Thursday, November 5, 2009. , A ...
Cached Medicine Technology:HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation 2Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009 2
(Date:9/3/2015)... New York (PRWEB) , ... September 03, 2015 , ... ... the Division of Trauma, Burns, Critical and Acute Care at NewYork-Presbyterian/Weill Cornell Medical Center, ... , Dr. Winchell is a nationally renowned expert in care for the critically injured ...
(Date:9/3/2015)... ... September 03, 2015 , ... As a result of the ... employer-sponsored health insurance plans, more employers are moving to a self-funded model for ... the 2014 United Benefit Advisors (UBA) Health Plan Survey. , UBA’s survey, the ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Hunters Creek ... Survivor Foundation with a champion AKC Black Lab Puppy. Celebrate Fall 2015 with unlimited ... for friends and family to enjoy Thanksgiving and Christmas with an extra big smile. ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We wish to ... impact the delicate life balance between work and leisure to the benefit of ... Leaptrott, CEO , A LifeMinder Plus® Emergency Care Document Set duly executed set ...
(Date:9/3/2015)... ... September 03, 2015 , ... “Love in Tokyo” an independent romantic comedy film ... Amazon and will be released on DVD early next year, by Maverick ... Itsuka, an actress and singer/songwriter, and Jason London, lead from “Dazed and Confused.” ...
Breaking Medicine News(10 mins):Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2
... Quest Diagnostics Incorporated (NYSE: DGX ), the world,s ... that its second quarter results will be made public on ... will hold its quarterly conference call with investors to discuss ... day. , , The public may access the conference ...
... 2009 - (BRONX, NY) - Elevated insulin levels in ... cancer in postmenopausal women, according to researchers at Albert ... are published in the online version of the ... risk for postmenopausal women has previously been linked to ...
... A state budget based entirely on cuts will accelerate ... state when the recession is over, according to a labor ... House leaders recently announced their intention to produce a no ... to Senate Bill 850, a bare-bones budget passed by the ...
... Foundation commends the nomination by President Obama of Francis Collins, ... of Health (NIH). , , "The CF Foundation is ... of the gene responsible for cystic fibrosis, may lead the ... is being highlighted by President Obama," said Robert J. Beall, ...
... , SAN DIEGO, July 9 CardioDynamics (Nasdaq: CDIC ... today reported financial results for fiscal second quarter 2009. Highlights ... growth compared with Q2 2008, the third consecutive quarter of year ... Highlights of Second Quarter 2009 Compared with Second Quarter 2008 ...
... , FT. LEE, N.J., July 9 Red wine (resveratrol) pills ... of cardiologists wants to lead the way for patients and consumers ... U.S. cardiologists to do so. , , (Photo: ... the heart-healthy properties of red wine pills, a local cardiology group ...
Cached Medicine News:Health News:Quest Diagnostics To Release Second Quarter Financial Results 2Health News:Einstein scientists link elevated insulin to increased breast cancer risk 2Health News:Deep Budget Cuts Will Add to Unemployment Rolls at Wrong Time 2Health News:Deep Budget Cuts Will Add to Unemployment Rolls at Wrong Time 3Health News:CF Foundation Supports President Obama's Nomination of Francis Collins, M.D., Ph.D., as New NIH Director 2Health News:CardioDynamics Reports Second Fiscal Quarter 2009 Results 2Health News:CardioDynamics Reports Second Fiscal Quarter 2009 Results 3Health News:CardioDynamics Reports Second Fiscal Quarter 2009 Results 4Health News:CardioDynamics Reports Second Fiscal Quarter 2009 Results 5Health News:Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions 2Health News:Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions 3Health News:Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions 4
... x 80 mm. Storz offers the ... by Harvey A. Lincoff, M.D. The ... which is non-toxic and non-antigenic. Implants ... minimize scleral intrusion. These implants are ...
... Size: 7.5 x 2.75 x 80 mm. Half ... by Harvey A. Lincoff, M.D. has been modified ... design. The material is a closed cell sponge ... with rounded edges to minimize scleral intrusion. These ...
For use under curved implants. Indications: When additional buckling is required in the meridional direction. Overall length: 12.0 mm....
For use with E5381 600 Circling Band (40 style)....
Medicine Products: